Item 9 Labs Corp. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2022 12 months to Sep 30, 2022	FY2021 12 months to Sep 30, 2021	FY2020 12 months to Sep 30, 2020	FY2019 12 months to Sep 30, 2019	FY2015 12 months to Sep 30, 2015
Revenues, net
Cost of revenues
Gross profit
General and administrative
Operating expenses
Professional fees and outside services
Payroll and employee related expenses
Sales and marketing
Depreciation and amortization
Other general and administrative expenses
Loss on assets held for sale
Loss on impairment
Provision for (recovery of) bad debt
Total expenses
Loss from operations
Other income (expense)
Interest income
Interest expense
Interest expense - related parties
Loss on deposits
Loss on impairment of intangible assets
Loss on extinguishment of debt
Other income
Total other income (expense), net

Net loss, before income tax provision (benefit)
Income tax provision (benefit)
Net loss from continuing operations
Net loss
Less: Net loss attributable to noncontrolling interest
Net loss attributable to Item 9 Labs Corp
Basic and diluted net loss per common share
Basic and diluted weighted average common shares outstanding
Less: Net loss attributable to non-controlling interest
Net loss attributable to Item 9 Labs Corp.
Basic net loss per common share
Basic weighted average common shares outstanding
Diluted net loss per common share
Diluted weighted average common shares outstanding

Comments